TABLE 1

Linear regression analyses of the association between age, current smoking and pulmonary function tests and parametric response mapping (PRM)

PRMfSADPRMEmphPRMPD
Age years#0.06** (0.04–0.08)0.05** (0.03–0.06)0.01* (0.00–0.01)
Current smoking−0.14 (−0.65–0.37)−0.42 (−0.89–0.05)0.24* (0.03–0.44)
Pulmonary function tests+
 FEV1 L0.18 (−0.47–0.83)0.27 (−0.33–0.86)−0.17 (−0.43–0.09)
 FEV1/FVC %0.06** (0.12– −0.01)−0.05 (−0.10–0.00)0.01 (−0.01–0.03)
 FEF25−75% L·s−1−0.28 (−0.62–0.06)−0.19 (−0.50–0.13)0.01 (−0.13–0.15)
 FEF25−75%/FVC s−12.29* (3.84– −0.75)1.73** (3.17– −0.29)0.33 (−0.32–0.98)
 RV L3.65** (0.19–7.11)1.01 (0.40–2.42)−0.44 (−4.72–3.83)
 TLC L0.56** (0.12–0.99)0.53** (0.13 –0.93)−0.11 (−0.29–0.07)
 RV/TLC %0.11* (0.04–0.17)0.08** (0.01 –0.14)0.01 (−0.02–0.04)
TLCOc/VA mmol·min−1·kPa−1·L−11.97** (3.55– −0.39)1.62** (3.08– −0.16)0.36 (−0.29–1.01)
R5R20 kPa·L−1·s−16.59** (12.2– −0.92)−4.84 (−10.11–0.43)0.41 (−0.19–2.76)
X5 kPa·L−1·s−14.92 (−3.51 –13.35)5.02 (−2.72–12.76)−0.62 (−4.04–2.80)
  • Data are presented as β (95% CI). PRM values were normalised by natural-logarithmic transformation. PRMfSAD: extent of small airway disease; PRMEmph: extent of emphysema; PRMPD: extent of parenchymal disease; FEV1: forced expiratory volume 1 s; FVC: forced vital capacity; FEF25–75%: forced expiratory flow at 25–75% of FVC; RV: residual volume; TLC: total lung capacity; TLCOc: transfer factor of the lung for carbon monoxide correction for haemoglobin; VA: alveolar volume; R5: resistance at 5 Hz; R20: resistance at 20 Hz; X5: reactance at 5 Hz. #: adjusted for sex and smoking status; : adjusted for sex and age; +: adjusted for age, sex, smoking status and height. Bold indicates statistically significant values. *: p<0.05; **: p<0.01.